Travere Therapeutics Pauses Enrollment In Phase 3 Study Of Pegtibatinase For Manufacturing Scale-Up
- Stock Market Stocks to buy Stocks to sell
admin
- 0
- 1 minute read
(RTTNews) – Travere Therapeutics Inc. (TVTX) announced a voluntary pause in enrollment for the Phase 3 HARMONY Study evaluating pegtibatinase for the treatment of classical homocystinuria (HCU). This decision follows the Company’s determination that the desired drug substance pro
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1486127040-2d871407d82744269fa20ef56224f5ef.jpg "Where Can You Buy Netspend Cards?")
:max_bytes(150000):strip_icc():format(jpeg)/ABeginnersGuidetoCallBuying-e0433db389da44ebb6dee9682d72e612.jpg "A Beginner’s Guide to Call Buying")
